Drug Type Small molecule drug |
Synonyms HP 749, HP-749, P 867493 + [1] |
Target |
Action antagonists |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), ADRA2 antagonists(Adrenergic receptors alpha-2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H17N3 |
InChIKeyOTPPJICEBWOCKD-UHFFFAOYSA-N |
CAS Registry119257-34-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Besipirdine | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 3 | United States | - | - |
| Urinary Bladder, Overactive | Phase 2 | France | - | |
| Urinary Bladder, Overactive | Phase 2 | - | - |





